Literature DB >> 907057

Hemostatic and platelet kinetic studies in dengue hemorrhagic fever.

C Mitrakul, M Poshyachinda, P Futrakul, N Sangkawibha, S Ahandrik.   

Abstract

In an attempt to reveal certain aspects of the pathogenesis of the bleeding disorder in dengue hemorrhagic fever, hemostatic and platelet kinetic studies were carried out in 61 children with this disease. As has been shown by others, thrombocytopenia and hypofibrinogenemia were the two most prominent hemostatic defects constantly discovered. Increased intravascular clotting seemed to be one responsible factor, though not an outstanding one. This was evidenced by mildly and variably low factors II, V, VII, VIII, IX, X, and XII, and by mild to moderate increase of fibrin degradation products as well as low platelet counts and fibrinogen. In 11 cases platelet kinetic study revealed increased destruction as a main cause for the thrombocytopenia, most probably due to the underlying immunologic mechanism, i.e., via the immune complexes formed. Another factor was platelet dysfunction--the release of adenosine diphosphate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 907057     DOI: 10.4269/ajtmh.1977.26.975

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Authors:  Allan R Brasier; Hyunsu Ju; Josefina Garcia; Heidi M Spratt; Sundar S Victor; Brett M Forshey; Eric S Halsey; Guillermo Comach; Gloria Sierra; Patrick J Blair; Claudio Rocha; Amy C Morrison; Thomas W Scott; Isabel Bazan; Tadeusz J Kochel
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.

Authors:  E D Hottz; M F Oliveira; P C G Nunes; R M R Nogueira; R Valls-de-Souza; A T Da Poian; A S Weyrich; G A Zimmerman; P T Bozza; F A Bozza
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

3.  Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.

Authors:  Allan R Brasier; Josefina Garcia; John E Wiktorowicz; Heidi M Spratt; Guillermo Comach; Hyunsu Ju; Adrian Recinos; Kizhake Soman; Brett M Forshey; Eric S Halsey; Patrick J Blair; Claudio Rocha; Isabel Bazan; Sundar S Victor; Zheng Wu; Susan Stafford; Douglas Watts; Amy C Morrison; Thomas W Scott; Tadeusz J Kochel
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

4.  Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation.

Authors:  Eugenio D Hottz; Juliana F Lopes; Carla Freitas; Rogério Valls-de-Souza; Marcus F Oliveira; Marcelo T Bozza; Andrea T Da Poian; Andrew S Weyrich; Guy A Zimmerman; Fernando A Bozza; Patricia T Bozza
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

5.  Comments on the clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile.

Authors:  Romélia Pinheiro Gonçalves Lemes
Journal:  Rev Bras Hematol Hemoter       Date:  2014-03

6.  Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.

Authors:  M Saito; K Oishi; S Inoue; E M Dimaano; M T P Alera; A M P Robles; B D Estrella; A Kumatori; K Moji; M T Alonzo; C C Buerano; R R Matias; K Morita; F F Natividad; T Nagatake
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

7.  Dengue Virus Infection Triggering Thrombotic Thrombocytopenic Purpura in Pregnancy.

Authors:  Surendran Deepanjali; Raghuramulu R Naik; Sharada Mailankody; Sivamani Kalaimani; Tamilarasu Kadhiravan
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

8.  Role of CD61+ cells in thrombocytopenia of dengue patients.

Authors:  Sansanee Noisakran; Nattawat Onlamoon; Kovit Pattanapanyasat; Hui-Mien Hsiao; Pucharee Songprakhon; Nasikarn Angkasekwinai; Kulkanya Chokephaibulkit; Francois Villinger; Aftab A Ansari; Guey Chuen Perng
Journal:  Int J Hematol       Date:  2012-09-18       Impact factor: 2.490

9.  Alternative complement pathway deregulation is correlated with dengue severity.

Authors:  Eduardo J M Nascimento; Ana M Silva; Marli T Cordeiro; Carlos A Brito; Laura H V G Gil; Ulisses Braga-Neto; Ernesto T A Marques
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

Review 10.  Is dengue a threat to the blood supply?

Authors:  D Teo; L C Ng; S Lam
Journal:  Transfus Med       Date:  2009-04       Impact factor: 2.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.